Back to search

Article

Additional biomarker other than HBsAg is required to determine Hepatitis B virus (HBV) functional cure in HIV/HBV coinfection

2024-07-26

Abstract excerpt

Among 1550 human immunodeficiency virus (HIV)/Hepatitis B virus (HBV) coinfected individuals receiving antiretroviral therapy (ART) over three years in Guangzhou, China, individuals (8.2%) achieved HBsAg loss. HBsAg loss was positively associated with a longer treatment (median 6.57 years) and a lower HBsAg level (median 645.2 COI) at the baseline. However, HBV pre-genomic RNA (pgRNA), a promising viral biomarker...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ba2d3250-f25f-5a66-9757-156890541116
DOI
10.22541/au.172202256.66303640/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Additional biomarker other than HBsAg is required to determine Hepatitis B virus (HBV) functional cure in HIV/HBV coinfectionDOI 10.22541/au.172202256.66303640/v1
Differential T-cell profiles determined by Hepatitis B surface antigen decrease among people with Human Immunodeficiency Virus /Hepatitis B Virus coinfection on treatment.Semantic proximity
Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers predicting HBsAg lossSemantic proximity
Epidemiological and clinical characteristics of hepatitis B virus in HIV-infected patients in Guangdong, China.Semantic proximity
Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog.Semantic proximity
Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patients.Semantic proximity
Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with pegylated interferon-α2a and adefovir.Semantic proximity
A higher correlation of HCV core antigen with CD4+ T cell counts compared with HCV RNA in HCV/HIV-1 coinfected patients.Semantic proximity
Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.Semantic proximity
Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.Semantic proximity
Quantification of HBsAg: basic virology for clinical practice.Semantic proximity
Predictive Factors for HBsAg Loss in Chronic HBeAg-Negative Hepatitis B Virus Infection: Insights From a 5-Year French Cohort.Semantic proximity
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.Semantic proximity
Select a neighboring publication to make it the new centre.